📰 Several Forms News

Several Forms News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Several Forms. Real-time updates on events, politics, business and more.

FDA Approves Trastuzumab Biosimilar to Treat Forms of HER2-Overexpressing Cancer

April 29, 2024

Trastuzumab is indicated for adjuvant breast cancer, metastatic breast cancer, and gastric cancer.

Chrys Kokino Fam Trastuzumab Deruxtecan Nxki Daiichi Sankyo Us Food Drug Administration Approval Accord Biopharma Inc Accord Biopharma

Source: pharmacytimes.com

Global Protein Alternatives Market to Reach $4.4 Billion by

June 10, 2022

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. ...

New York United States High Market South Korea Entofoodsdn Bhd Mycotechnology Inc

Source: globenewswire.com

Global Protein Ingredients Market to Reach $73.9 Billion

March 30, 2022

Abstract: What`s New for 2022? -Global competitiveness and key competitor percentage market shares. ...

New York United States United Kingdom New South Wales South Korea Arla Foods Ingredients Group

Source: globenewswire.com

Global Protein Alternatives Market Report 2020-2027: COVID-19 Induced Fears of Animal Borne Diseases, Accelerates the Shift to Protein Alternatives

December 16, 2020

Share this article Share this article ResearchAndMarkets.coms offering. COVID-19 Accelerates Acceptance of Vegetarianism & Also the Emphasis on the Environment. Protein Alternatives to Gain $4.7 Billion on Both Counts The global market for Protein Alternatives is projected to reach US$4.7 billion by the year 2027, trailing a post COVID-19 CAGR of 8% over the analysis period 2020 through 2027. Non-animal based sources of protein are environmentally sustainable as compared to crop and animal ba...

United States United Kingdom Laura Wood Custom Research Dowdupont Inc Office Hours Call

Source: prnewswire.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation